Blb&B Advisors, LLC Pfizer Inc Transaction History

Blb&B Advisors, LLC

$1.95 Billion
Q3 2024

A detailed history of Blb&B Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Blb&B Advisors, LLC holds 90,031 shares of PFE stock, worth $2.41 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

90,031

Previous 91,322 1.41%

Holding current value

$2.41 Million

Previous $2.56 Million 1.96%

% of portfolio

0.13%

Previous 0.14%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$27.7 - $31.39 $35,760 - $40,524	-1,291 Reduced 1.41%	90,031 $2.61 Million
Q2 2024 Jul 26, 2024	SELL	$25.26 - $29.6 $378,470 - $443,496	-14,983 Reduced 14.09%	91,322 $2.56 Million
Q1 2024 Apr 26, 2024	SELL	$25.89 - $29.73 $298,900 - $343,232	-11,545 Reduced 9.8%	106,305 $2.95 Million
Q4 2023 Jan 19, 2024	SELL	$26.13 - $33.94 $702,687 - $912,714	-26,892 Reduced 18.58%	117,850 $3.39 Million
Q3 2023 Oct 24, 2023	SELL	$32.09 - $37.51 $307,935 - $359,945	-9,596 Reduced 6.22%	144,742 $4.8 Million
Q2 2023 Jul 20, 2023	SELL	$36.12 - $41.79 $213,433 - $246,937	-5,909 Reduced 3.69%	154,338 $5.66 Million
Q1 2023 Apr 21, 2023	SELL	$39.39 - $51.28 $238,545 - $310,551	-6,056 Reduced 3.64%	160,247 $6.54 Million
Q4 2022 Jan 17, 2023	SELL	$41.75 - $54.5 $318,677 - $415,998	-7,633 Reduced 4.39%	166,303 $0
Q3 2022 Oct 14, 2022	SELL	$43.76 - $53.42 $181,516 - $221,586	-4,148 Reduced 2.33%	173,936 $7.61 Million
Q2 2022 Jul 18, 2022	SELL	$46.53 - $55.17 $357,489 - $423,871	-7,683 Reduced 4.14%	178,084 $9.34 Million
Q1 2022 Apr 20, 2022	SELL	$45.75 - $56.69 $29,051 - $35,998	-635 Reduced 0.34%	185,767 $9.62 Million
Q4 2021 Jan 21, 2022	SELL	$41.32 - $61.25 $535,094 - $793,187	-12,950 Reduced 6.5%	186,402 $11 Million
Q3 2021 Oct 19, 2021	SELL	$39.25 - $50.42 $523,398 - $672,350	-13,335 Reduced 6.27%	199,352 $8.57 Million
Q2 2021 Jul 20, 2021	SELL	$35.91 - $40.68 $1.09 Million - $1.23 Million	-30,343 Reduced 12.49%	212,687 $8.33 Million
Q1 2021 Apr 19, 2021	SELL	$33.49 - $37.77 $596,758 - $673,023	-17,819 Reduced 6.83%	243,030 $8.81 Million
Q4 2020 Jan 19, 2021	BUY	$33.47 - $42.56 $25,102 - $31,920	750 Added 0.29%	260,849 $9.6 Million
Q3 2020 Oct 20, 2020	SELL	$31.75 - $37.25 $142,557 - $167,252	-4,490 Reduced 1.7%	260,099 $9.55 Million
Q2 2020 Jul 16, 2020	SELL	$30.12 - $36.54 $445,083 - $539,951	-14,777 Reduced 5.29%	264,589 $8.65 Million
Q1 2020 Apr 21, 2020	SELL	$27.03 - $38.62 $447,427 - $639,276	-16,553 Reduced 5.59%	279,366 $9.12 Million
Q4 2019 Jan 21, 2020	SELL	$32.92 - $37.36 $484,253 - $549,565	-14,710 Reduced 4.74%	295,919 $11.6 Million
Q3 2019 Oct 22, 2019	SELL	$32.49 - $42.13 $58,482 - $75,834	-1,800 Reduced 0.58%	310,629 $11.2 Million
Q2 2019 Jul 29, 2019	SELL	$36.98 - $41.52 $224,061 - $251,569	-6,059 Reduced 1.9%	312,429 $13.5 Million
Q1 2019 Apr 19, 2019	BUY	$37.5 - $41.2 $13,425 - $14,749	358 Added 0.11%	318,488 $13.5 Million
Q4 2018 Jan 17, 2019	SELL	$38.47 - $43.86 $439,789 - $501,407	-11,432 Reduced 3.47%	318,130 $13.9 Million
Q3 2018 Oct 12, 2018	BUY	$34.47 - $41.81 $349,456 - $423,869	10,138 Added 3.17%	329,562 $14.5 Million
Q2 2018 Jul 11, 2018	SELL	$32.98 - $35.16 $2.18 Million - $2.32 Million	-65,989 Reduced 17.12%	319,424 $11.6 Million
Q1 2018 Apr 09, 2018	BUY	$31.91 - $37.02 $4.44 Million - $5.15 Million	139,063 Added 56.45%	385,413 $13.7 Million
Q4 2017 Jan 16, 2018	SELL	$33.26 - $35.29 $221,677 - $235,207	-6,665 Reduced 2.63%	246,350 $8.92 Million
Q3 2017 Oct 16, 2017	BUY	$31.0 - $34.15 $7.84 Million - $8.64 Million	253,015	253,015 $9.03 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blb&B Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blb&B Advisors, LLC with notifications on news.

Account

Blb&B Advisors, LLC Pfizer Inc Transaction History